JPMorgan Analysts Say Obesity Drugs Could Weigh on Alcohol Sales
JPMorgan analysts cite the bank’s survey as indicating further growth in GLP-1 drug use; they say greater penetration could hurt beer, spirits and wine sales.
JPMorgan analysts cite the bank’s survey as indicating further growth in GLP-1 drug use; they say greater penetration could hurt beer, spirits and wine sales.